We have had this duiscussion on the board before! The issue is with chronic use of "PO" tylenol which is taken subchronically and/or chronically. CADX IV version is used acutely a few times and then stopped because of the nature of the route of administration.
If this is causing CADX drop today, then its totally stupid and not based on medicine! its market shenannigans!
Oh I bought some more---if this goes below 5.00 based on the fundamentals, then somebody is basically trying to destroy the company as no fundamentals support this action!But I am not buying anymore--no sense researching a lack of common sense to the PPS action!
From a physicians perspective, the warning is irrelevant and in fact previously known. Furthermore the warning is for Oral Tylenol not IV. The path to metabolism is fairly different between the two, this is why the IV formulation is vastly less toxic to the liver. Warnings like this might affect an over the counter drug but will have no impact whatsoever on physician decision to use Ofirmev. In case anyone is curious about huge side effect profile differences oral vs IV just look at testosterone.